Evaluation of [18F]MNI-1126 as an Imaging Marker for Synaptic Density Loss

Status:
Completed

Trial end date:
2020-02-26

Target enrollment:

Participant gender:

The primary objective of this protocol is to examine [18F]MNI-1126 as a tool to assess synaptic density loss.

Phase 1

Invicro